MedTech Innovator

MastOR SAS is a medical device company based in Paris, France, founded in 2019. The company focuses on developing a surgical robot designed to assist with laparoscopy, a minimally invasive surgical technique. This innovative platform aims to enhance access to advanced surgical procedures for surgeons and improve resource utilization in operating rooms. By providing tools that facilitate laparoscopy, MastOR seeks to advance surgical practices and patient care.

DermaSensor, Inc. develops a hand-held device that uses artificial intelligence to evaluate skin lesions for cancer. It offers DermaSensor, a device that allows physicians and consumers to perform skin checks in physician offices and patient homes. The company’s device is also used for lesion identification, scanning, photon scattering, and algorithmic analysis. DermaSensor, Inc. was founded in 2009 and is based in Miami, Florida.

Aqua Medical, Inc. develops a disruptive, vapor-based, endoscopic, ablation technology to treat gastrointestinal (GI) disease and prevent GI cancers. Its ablation technology includes high temperature water vapor created by a radio frequency generator and delivered endoscopically through proprietary catheters to the GI tract. The company’s platform technology uses a vapor generator system with two catheter types to deliver treatment for multiple diseases throughout the GI tract. The company was incorporated in 2016 and is based in Santa Ana, California.

Digma Medical is a clinical stage medical device company established in 2013, focused on innovating treatments for Type-2 Diabetes and related metabolic syndromes, including NASH. The company is developing the DiaGone™, an endoscopic and disposable device that employs advanced laser technology to treat the duodenum without the need for an implant. The Duodenal Glycemic Control™ procedure, which lasts approximately 30 minutes, allows gastroenterologists to use the DiaGone™ to enhance the body's ability to regulate glucose levels. This approach aims to offer patients the potential for long-term remission from Type-2 Diabetes and other metabolic conditions, thereby improving their overall quality of life and health outcomes. Supported by prominent venture capital firms, Digma Medical is dedicated to advancing effective therapies for diabetes management.

Leadoptik is a California-based company operating in stealth mode, focused on developing advanced miniature imaging technology for minimally invasive medical procedures. This innovative technology enhances surgeons' ability to view small objects with improved clarity compared to existing imaging systems, offering 3D navigation capabilities and high-resolution imaging. By facilitating the early detection of cancer in patients, Leadoptik aims to significantly improve surgical outcomes and patient care.

Embolx, Inc. is a medical device manufacturer based in Sunnyvale, California, focused on creating catheter-based systems for cancer treatment. Founded in 2013, the company has developed innovative devices such as the Sniper, a drug delivery balloon microcatheter that enhances the precision of delivering therapeutic agents directly to tumors while minimizing the risk of affecting surrounding healthy tissues. Utilizing a technique known as Low Pressure Embolization (LPE), Embolx's devices regulate pressure to improve drug distribution within the tumor and eliminate non-target delivery. This technology aims to set a new standard in minimally invasive localized cancer therapy, while also addressing conditions such as benign prostatic hyperplasia and uterine fibroids.

HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation.

AxioSonic is a developer of non-invasive treatment intended to treat chronic sinusitis. It uses a proprietary multimodal frequency system to treat facial pain and reduce symptoms of chronic sinusitis without the use of any medication, enabling healthcare providers to improve pain scores, sinus symptom scores, and patient outcomes. The company was founded in 2015 and is headquartered in Effingham, Illinois.

Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Founded in 2013, the company specializes in developing advanced electrosurgical devices, particularly focusing on radiofrequency ablation technology. One of its key innovations is the Sira™ device, a saline-assisted intraoperative radiofrequency ablation tool that employs bipolar current to create a controlled zone of ablation. Sira's unique design, featuring a saline microinfusion system, enhances contact with target tissue and is compatible with standard electrosurgical generators already utilized in operating rooms. This technology offers surgeons a new, effective option for intraoperative ablation of soft tissue, promoting ease of use and adoption in surgical practices.

GreenLight Medical, Inc. is a cloud-based platform that facilitates the procurement process for medical devices within hospitals. Founded in 2014 and headquartered in Nashville, Tennessee, the company offers a software-as-a-service tool designed to enhance the decision-making process regarding medical technology purchases. The platform serves as a collaborative space for hospitals, medical suppliers, and other stakeholders, enabling streamlined workflows and effective project management. By connecting all parties involved, GreenLight Medical promotes cost-effective and quality-conscious purchasing decisions. It manages the entire sales cycle, from the introduction of medical device companies to their approval and use in healthcare facilities, providing actionable data and insights to improve the procurement process.

Avenda Health Inc. is focused on developing a minimally invasive treatment for prostate cancer through its artificial intelligence-based focal laser ablation system. This innovative technology includes a fiber-optic laser and a disposable sensor, which work together with a feedback control system to provide precise treatments. The system integrates prostate images and biopsies using MRI-ultrasound fusion for guidance, allowing procedures to be performed under local anesthesia. Avenda Health aims to deliver safe, effective, and cost-efficient alternatives for patients, enhancing their quality of life while undergoing outpatient treatment. Founded in 2017, the company is headquartered in Santa Monica, California.

Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.

LensGen, Inc. is an ophthalmic medical device company based in Irvine, California, that focuses on developing innovative solutions for presbyopia and cataracts. Founded in 2011, the company has created a biomimetic, curvature-changing intraocular lens designed to mimic the natural human lens. This lens, known as Juvene™, utilizes the eye's natural muscle contractions to adjust its shape and dioptric power on demand, allowing for clear and continuous vision at all distances. By restoring youthful vision, LensGen's technology eliminates the need for reading glasses, offering a significant advancement in the treatment of age-related vision issues.

LensGen, Inc. is an ophthalmic medical device company based in Irvine, California, that focuses on developing innovative solutions for presbyopia and cataracts. Founded in 2011, the company has created a biomimetic, curvature-changing intraocular lens designed to mimic the natural human lens. This lens, known as Juvene™, utilizes the eye's natural muscle contractions to adjust its shape and dioptric power on demand, allowing for clear and continuous vision at all distances. By restoring youthful vision, LensGen's technology eliminates the need for reading glasses, offering a significant advancement in the treatment of age-related vision issues.